跳到主要內容
Font Size
A
A
A
轉寄 轉寄
(Exclusive License) Technology Transfer Enterprise Selection Announcement - Use of adipose‐derived mesenchymal stem cells for preparing pharmaceutical compositions for treating keratoconjunctivitis sicca
Date of Announcement
2022-03-22

1、Technology:Use of adipose‐derived mesenchymal stem cells for preparing pharmaceutical compositions for treating keratoconjunctivitis sicca

 

2、Provider:

Prof. I‐Hsuan Liu
Department of Animal Science and Technology, National Taiwan University

Prof. Chung‐Tien Lin
Institute of Veterinary Clinical Science, National Taiwan University

 

3、Enterprise Eligibility:

(1) Industry Category:No specific restrictions

(2) Required Technical Know-how:No specific restrictions

(3) Required Machinery and Equipment:No specific restrictions

(4) Required Research or Technical Staff:No specific restrictions

(5) Other Requirements:No specific restrictions

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

 

4、How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

5、Announcement Date2022/03/22 ~ 2022/04/05

 

 

Intellectual Property & Licensing Manager  / Sierra Wang

TEL: +886-2-33669954

Email: sierrawang@ntu.edu.tw

File download:
TechnologyTransferEnterpriseSelectionAnnouncement-Useofadipose‐derivedmesenchymalstemcellsforpreparingpharmaceutical
File size: 625kb